Results 161 to 170 of about 9,955 (227)

Improved 24-hour urine parameters associated with reduced symptomatic kidney stone recurrence. [PDF]

Urolithiasis
Sui W, Yang H, Escobar MC, Maalouf F, Suarez P, Chi T, Stoller ML.   +6 more
europepmc   +1 more source

Chronic leg ulcers in a patient with Hyperoxaluria type 1: a rare and challenging diagnosis. [PDF]

Oxf Med Case Reports
Kabbou S, Eljouari O, Gallouj S.
europepmc   +1 more source

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1. [PDF]

J Pers Med
Dotis J, Fourikou M.
europepmc   +1 more source

A novel synbiotic formulation prevents calcium oxalate stones by restoring gut microbiota homeostasis. [PDF]

BMC Microbiol
Li XM, Amier Y, Wan WL, Wang YQ, Lyu GR, Lu JL, Rao JY, Yang YY, Xun Y, Yu X.   +9 more
europepmc   +1 more source

Probiotics in the prevention and treatment of calcium oxalate kidney stones: mechanisms and therapeutic potential. [PDF]

Front Microbiol
Yang J, Li D, Li T, Jia B.
europepmc   +1 more source

Recurrent vomiting in a 12-year old boy with diagnostic suspicion of hyperoxaluria : a case report [PDF]

, 2016
Dossche, Lien, Raes, Ann, Van Renterghem, Katrien, Vande Velde, Saskia, Vande Walle, Johan   +4 more
core   +1 more source

Primary Hyperoxaluria Type 2 Masquerading as Chronic Kidney Disease of Unknown Origin in an Adolescent: A Case Report. [PDF]

Cureus
Garg M, Garg S, Mondal M, Acharya P, Garg L.   +4 more
europepmc   +1 more source

Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands. [PDF]

Nephrol Dial Transplant
Deesker LJ, Franssen CFM, Dorresteijn E, van de Kar NCAJ, Nurmohamed SA, Severs D, Garrelfs SF, Pisters-van Roy AAMG, Hollak CEM, Groothoff JW.   +9 more
europepmc   +1 more source

Metabolic abnormalities in pure vs. mixed struvite stone formers: A retrospective comparative analysis utilising large language models for data extraction. [PDF]

BJUI Compass
Velasquez Ospina J, Bhatia A, Khandekar A, Rathinam A, Austin G, Katz J, Marcovich R, Shah HN.   +7 more
europepmc   +1 more source

Optimizing Screening Performance for the Risk of Hyperoxaluria and Urolithiasis Using the Urinary Oxalate/Creatinine Ratio: A Retrospective Analysis. [PDF]

Eur Urol Open Sci
Letourneau P, Cabezas L, De Mul A, Abid N, Machon C, Poussineau C, Acquaviva C, Bacchetta J, Derain-Dubourg L, Lemoine S.   +9 more
europepmc   +1 more source